Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Baxter
Merck
Daiichi Sankyo
UBS
Julphar
Argus Health
Harvard Business School

Generated: April 19, 2018

DrugPatentWatch Database Preview

PROAMATINE Drug Profile

« Back to Dashboard

Which patents cover Proamatine, and when can generic versions of Proamatine launch?

Proamatine is a drug marketed by Shire Llc and is included in one NDA.

The generic ingredient in PROAMATINE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.
Drug patent expirations by year for PROAMATINE
Pharmacology for PROAMATINE
Medical Subject Heading (MeSH) Categories for PROAMATINE
Synonyms for PROAMATINE
( -)-Midodrin hydrochloride
( -)-Midodrine hydrochloride
( inverted exclamation markA)-Midodrine
(-)-Midodrin hydrochloride
(-)-Midodrine hydrochloride
(+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride
(+-)-Midodrin hydrochloride
(+-)-Midodrine hydrochloride
(+/-)-Midodrine
(RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid
[+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol
092M179
1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
133163-28-7
2- degrees +/->>u-N-[2-(2,5- paragraph signthorn(1/4)xNo>>u+/-(1/2)>>u)-2-oCOO>>u]OOo pound degrees .
2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide
2-AMINO-N-[2-(2,5-DIMETHOXYPHENYL)-2-HYDROXY-ETHYL]ACETAMIDE
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-acetamide hydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride
2-Amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide monohydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide, chloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]ethanimidic acid
2-azanyl-N-[2-(2,5-dimethoxyphenyl)-2-oxidanyl-ethyl]ethanamide hydrochloride
218M560
3092-17-9
3092-17-9 (mono-hydrochloride)
42794-76-3
43218-56-0
97476-58-9
A 4020 Linz
A-4020 Linz
A820652
AB00053715
AB00053715_08
AC1L1HMJ
AC1L2BU9
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride, (+-)-
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, monohydrochloride, (+-)-
ACETAMIDE,2-AMINO-N-[2-(2,5-DIMETHOXYPHENYL)-2-HYDROXYETHYL]-
ACM43218560
AKOS015895724
AKOS015967099
Alphamine
Amatine
API0001437
API0024416
BPBio1_000157
BRD-A79981887-003-05-7
BSPBio_000141
BSPBio_003150
C-23717
C07890
C12H18N2O4
C12H18N2O4.HCl
C12H19ClN2O4
CAS-3092-17-9
CC-30954
CCG-39323
CHEBI:31847
CHEBI:6933
CHEMBL1200461
CHEMBL1201212
CPD000058833
CS-4688
CS-4689
CTK1D6108
CTK5H9352
D01307
D02XJY
D08220
DA-05918
DB00211
DivK1c_000955
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DR000703
DSSTox_CID_27493
DSSTox_GSID_47493
DSSTox_RID_82380
DTXSID0023321
DTXSID1047493
EINECS 255-945-3
EINECS 256-148-3
FT-0603627
FT-0701302
FT-0740719
GTPL7240
Gutron
Hipertan
HMS1568H03
HMS1922O03
HS-0099
HSDB 7854
HY-12749
HY-12749A
I06-0865
IDI1_000955
KB-283180
KBio1_000955
KBio2_002121
KBio2_004689
KBio2_007257
KBio3_002650
KBioGR_000763
KBioSS_002121
LS-174957
LS-8042
LS-8052
MCULE-7047456030
MCULE-8615039451
Metligene
MGCQZNBCJBRZDT-UHFFFAOYSA-N
Midamine
Midodrin
Midodrina
Midodrina [INN-Spanish]
midodrine
Midodrine (hydrochloride)
Midodrine (INN)
Midodrine [BAN:INN]
Midodrine [INN:BAN]
Midodrine HCL
MIDODRINE HYDROCHLORIDE
Midodrine hydrochloride (JAN/USAN)
Midodrine hydrochloride [USAN:JAN]
Midodrine hydrochloride [USAN:USP:JAN]
Midodrine hydrochloride [USAN]
Midodrine hydrochloride, analytical standard, for drug analysis
Midodrine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Midodrine Monohydrochloride
Midodrinum
Midodrinum [INN-Latin]
MLS001332567
MLS001332568
MLS002154233
MolPort-003-666-473
N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide
N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide
NC00573
NCGC00016620-01
NCGC00095311-01
NCGC00178238-01
NCGC00178238-02
NCGC00178238-05
NCGC00256810-01
NINDS_000955
NSC-758429
NSC758429
OR214095
OR270228
Pharmakon1600-01503257
Prestwick_625
Prestwick0_000191
Prestwick1_000191
Prestwick2_000191
Prestwick3_000191
Pro-Amatine
Pro-Amatine (TN)
ProAmatine (TN)
PTKSEFOSCHHMPD-UHFFFAOYSA-N
Q-201404
rac-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide
rac-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide hydrochloride
s120
SAM002564219
SBB066174
SBI-0051934.P002
SCHEMBL131436
SCHEMBL41463
SMR000058833
SPBio_001390
SPBio_002062
Spectrum_001641
SPECTRUM1503257
Spectrum2_001545
Spectrum3_001585
Spectrum4_000192
Spectrum5_000962
St 1085
St 1085 [as the base]
ST-1085
ST-1085 [As The Base]
St. Peter 224
ST51037351
TL8002369
Tox21_110529
Tox21_110529_1
Tox21_302723
TS 701
VA11298

US Patents and Regulatory Information for PROAMATINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Llc PROAMATINE midodrine hydrochloride TABLET;ORAL 019815-001 Sep 6, 1996 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Shire Llc PROAMATINE midodrine hydrochloride TABLET;ORAL 019815-002 Sep 6, 1996 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Shire Llc PROAMATINE midodrine hydrochloride TABLET;ORAL 019815-003 Mar 20, 2002 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Cantor Fitzgerald
Chubb
Julphar
AstraZeneca
Harvard Business School
Cerilliant
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.